Screener
Sutro Biopharma STRO Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 128,876 | 83,298 |
| Accounts receivable | 12,484 | 3,977 |
| Prepaid expenses and other current assets | 5,930 | 5,521 |
| Total current assets | 220,972 | 150,926 |
| Property and equipment, net | 9,363 | 10,648 |
| Operating lease right-of-use assets | 9,707 | 10,903 |
| Other non-current assets | 1,088 | 495 |
| Restricted cash | 858 | 858 |
Item 1. Financial Statements.
FAQ
- What is Sutro Biopharma's total current assets?
- Sutro Biopharma (STRO) reported total current assets of $220.97M in Q1 2026.
- How has Sutro Biopharma's total current assets changed year-over-year?
- Sutro Biopharma's total current assets decreased by 23.1% year-over-year, from $287.41M to $220.97M.
- What is the long-term trend for Sutro Biopharma's total current assets?
- Over 5 years (2020 to 2025), Sutro Biopharma's total current assets has grown at a -16.8% compound annual growth rate (CAGR), from $378.18M to $150.93M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Sutro Biopharma's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude